Structure of the membrane proximal external region of HIV-1 envelope glycoprotein

Significance The conserved, membrane-proximal external region (MPER) of the HIV-1 envelope glycoprotein (Env) is a potential vaccine target. To visualize its structure in the context of a lipid-bilayer membrane, we have reconstituted a polypeptide containing the HIV-1 MPER and the contiguous transmembrane domain into a bilayer-like environment and determined its atomic structure by NMR. The MPER folds into a trimeric cluster, well exposed on the bilayer surface, even in the absence of the structural constraints from the rest of the Env ectodomain. Our analyses suggest that this structure probably represents a prefusion conformation of the MPER. The findings imply that presenting a well-defined structure will be important for MPER-based immunogen design. The membrane-proximal external region (MPER) of the HIV-1 envelope glycoprotein (Env) bears epitopes of broadly neutralizing antibodies (bnAbs) from infected individuals; it is thus a potential vaccine target. We report an NMR structure of the MPER and its adjacent transmembrane domain in bicelles that mimic a lipid-bilayer membrane. The MPER lies largely outside the lipid bilayer. It folds into a threefold cluster, stabilized mainly by conserved hydrophobic residues and potentially by interaction with phospholipid headgroups. Antigenic analysis and comparison with published images from electron cryotomography of HIV-1 Env on the virion surface suggest that the structure may represent a prefusion conformation of the MPER, distinct from the fusion-intermediate state targeted by several well-studied bnAbs. Very slow bnAb binding indicates that infrequent fluctuations of the MPER structure give these antibodies occasional access to alternative conformations of MPER epitopes. Mutations in the MPER not only impede membrane fusion but also influence presentation of bnAb epitopes in other regions. These results suggest strategies for developing MPER-based vaccine candidates.

[1]  A. Bax,et al.  Tilted, Uninterrupted, Monomeric HIV-1 gp41 Transmembrane Helix from Residual Dipolar Couplings. , 2018, Journal of the American Chemical Society.

[2]  John P. Moore,et al.  Open and Closed Structures Reveal Allostery and Pliability in the HIV-1 Envelope Spike , 2017, Nature.

[3]  Andreia M. Serra,et al.  Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design , 2017, PLoS pathogens.

[4]  Jonathan R. McDaniel,et al.  Potent and broad HIV-neutralizing antibodies in memory B cells and plasma , 2017, Science Immunology.

[5]  J. Chou,et al.  Optimal Bicelle Size q for Solution NMR Studies of the Protein Transmembrane Partition. , 2017, Chemistry.

[6]  G. Jensen,et al.  Cryo-EM structure of a CD4-bound open HIV-1 envelope trimer reveals structural rearrangements of the gp120 V1V2 loop , 2016, Proceedings of the National Academy of Sciences.

[7]  M. Nussenzweig,et al.  Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site , 2016, Nature Structural &Molecular Biology.

[8]  T. Kepler,et al.  Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity , 2016, EBioMedicine.

[9]  Michael S. Seaman,et al.  Structural basis for membrane anchoring of HIV-1 envelope spike , 2016, Science.

[10]  J. C. Love,et al.  Generation of Long-Lived Bone Marrow Plasma Cells Secreting Antibodies Specific for the HIV-1 gp41 Membrane-Proximal External Region in the Absence of Polyreactivity , 2016, Journal of Virology.

[11]  T. Kepler,et al.  Initiation of immune tolerance–controlled HIV gp41 neutralizing B cell lineages , 2016, Science Translational Medicine.

[12]  A. Ward,et al.  Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer , 2016, Science.

[13]  Prabuddha Sengupta,et al.  Structural Basis and Functional Role of Intramembrane Trimerization of the Fas/CD95 Death Receptor. , 2016, Molecular cell.

[14]  I. Wilson,et al.  Crystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10. , 2016, Immunity.

[15]  Ben Murrell,et al.  Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort , 2016, PLoS pathogens.

[16]  Hanqin Peng,et al.  Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein , 2015, Science.

[17]  J. Dorfman,et al.  Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency , 2015, Journal of Virology.

[18]  B. Haynes,et al.  Polyreactivity and Autoreactivity among HIV-1 Antibodies , 2014, Journal of Virology.

[19]  Tongqing Zhou,et al.  Structure and immune recognition of trimeric prefusion HIV-1 Env , 2014, Nature.

[20]  B. Clotet,et al.  Anti-MPER antibodies with heterogeneous neutralization capacity are detectable in most untreated HIV-1 infected individuals , 2014, Retrovirology.

[21]  L. Stamatatos,et al.  Faculty Opinions recommendation of Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer. , 2014 .

[22]  John P. Moore,et al.  Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer , 2013, Science.

[23]  Hanqin Peng,et al.  Mechanism of HIV-1 Neutralization by Antibodies Targeting a Membrane-Proximal Region of gp41 , 2013, Journal of Virology.

[24]  Florian Klein,et al.  Antibodies in HIV-1 Vaccine Development and Therapy , 2013, Science.

[25]  H. Liao,et al.  Induction of HIV-1 Broad Neutralizing Antibodies in 2F5 Knock-in Mice: Selection against Membrane Proximal External Region–Associated Autoreactivity Limits T-Dependent Responses , 2013, The Journal of Immunology.

[26]  J. Mascola,et al.  Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning , 2013, Nature Reviews Immunology.

[27]  B. Haynes,et al.  Common Tolerance Mechanisms, but Distinct Cross-Reactivities Associated with gp41 and Lipids, Limit Production of HIV-1 Broad Neutralizing Antibodies 2F5 and 4E10 , 2013, The Journal of Immunology.

[28]  W. Weissenhorn,et al.  A gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen Recognition , 2013, PLoS pathogens.

[29]  T. Kepler,et al.  Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies , 2013, The Journal of experimental medicine.

[30]  Baoshan Zhang,et al.  Broad and potent neutralization of HIV-1 by a gp41-specific human antibody , 2012, Nature.

[31]  E. Reinherz,et al.  Antibody mechanics on a membrane-bound HIV segment essential for GP41-targeted viral neutralization , 2011, Nature Structural &Molecular Biology.

[32]  T. Kepler,et al.  Isolation of a Human Anti-HIV gp41 Membrane Proximal Region Neutralizing Antibody by Antigen-Specific Single B Cell Sorting , 2011, PloS one.

[33]  Pham Phung,et al.  Broad neutralization coverage of HIV by multiple highly potent antibodies , 2011, Nature.

[34]  Ron Diskin,et al.  Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding , 2011, Science.

[35]  S. Zolla-Pazner,et al.  Comparative Magnitude of Cross-Strain Conservation of HIV Variable Loop Neutralization Epitopes , 2010, PloS one.

[36]  M. Chance,et al.  Structural Characterization of HIV gp41 with the Membrane-proximal External Region* , 2010, The Journal of Biological Chemistry.

[37]  Felix Campelo,et al.  Crystal Structure of HIV-1 gp41 Including Both Fusion Peptide and Membrane Proximal External Regions , 2010, PLoS pathogens.

[38]  B. Haynes,et al.  Prolonged exposure of the HIV-1 gp41 membrane proximal region with L669S substitution , 2010, Proceedings of the National Academy of Sciences.

[39]  C. Broder,et al.  Anti-gp41 Antibodies Cloned from HIV-Infected Patients with Broadly Neutralizing Serologic Activity , 2010, Journal of Virology.

[40]  D. Burton,et al.  Aromatic residues at the edge of the antibody combining site facilitate viral glycoprotein recognition through membrane interactions , 2010, Proceedings of the National Academy of Sciences.

[41]  H. Liao,et al.  Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance , 2009, Proceedings of the National Academy of Sciences.

[42]  H. Liao,et al.  Role of HIV membrane in neutralization by two broadly neutralizing antibodies , 2009, Proceedings of the National Academy of Sciences.

[43]  Pham Phung,et al.  Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target , 2009, Science.

[44]  A. Bax,et al.  TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts , 2009, Journal of biomolecular NMR.

[45]  D. Burton,et al.  A Conformational Switch in Human Immunodeficiency Virus gp41 Revealed by the Structures of Overlapping Epitopes Recognized by Neutralizing Antibodies , 2009, Journal of Virology.

[46]  E. Reinherz,et al.  Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface , 2009, Proceedings of the National Academy of Sciences.

[47]  John P. Moore,et al.  Structure of the HIV-1 gp41 membrane-proximal ectodomain region in a putative prefusion conformation. , 2009, Biochemistry.

[48]  G. Sapiro,et al.  Molecular architecture of native HIV-1 gp120 trimers , 2008, Nature.

[49]  Yifan Cheng,et al.  A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies , 2008, Proceedings of the National Academy of Sciences.

[50]  Jamie K. Scott,et al.  The Membrane-Proximal External Region of the Human Immunodeficiency Virus Type 1 Envelope: Dominant Site of Antibody Neutralization and Target for Vaccine Design , 2008, Microbiology and Molecular Biology Reviews.

[51]  V. Brusic,et al.  HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane. , 2008, Immunity.

[52]  Ian A Wilson,et al.  Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10. , 2007, Journal of molecular biology.

[53]  J. Lifson,et al.  Distribution and three-dimensional structure of AIDS virus envelope spikes , 2006, Nature.

[54]  S. Harrison Mechanism of Membrane Fusion by Viral Envelope Proteins , 2005, Advances in Virus Research.

[55]  Renate Kunert,et al.  Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies , 2005, Science.

[56]  Peter D. Kwong,et al.  Structure and Mechanistic Analysis of the Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5 in Complex with Its gp41 Epitope , 2004, Journal of Virology.

[57]  R. Blumenthal,et al.  Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion. , 2003, Biochemistry.

[58]  Martin A. Nowak,et al.  Antibody neutralization and escape by HIV-1 , 2003, Nature.

[59]  D. Richman,et al.  Rapid evolution of the neutralizing antibody response to HIV type 1 infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[60]  H. Katinger,et al.  A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. , 2001, AIDS research and human retroviruses.

[61]  G. Wider,et al.  Improved sensitivity and coherence selection for [15N,1H]-TROSY elements in triple resonance experiments , 1999, Journal of biomolecular NMR.

[62]  E. Hunter,et al.  Role of the Membrane-Proximal Domain in the Initial Stages of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein-Mediated Membrane Fusion , 1999, Journal of Virology.

[63]  E. Hunter,et al.  A Conserved Tryptophan-Rich Motif in the Membrane-Proximal Region of the Human Immunodeficiency Virus Type 1 gp41 Ectodomain Is Important for Env-Mediated Fusion and Virus Infectivity , 1999, Journal of Virology.

[64]  J. Bonifacino,et al.  A Membrane-proximal Tyrosine-based Signal Mediates Internalization of the HIV-1 Envelope Glycoprotein via Interaction with the AP-2 Clathrin Adaptor* , 1998, The Journal of Biological Chemistry.

[65]  P. S. Kim,et al.  HIV Entry and Its Inhibition , 1998, Cell.

[66]  S. Harrison,et al.  Atomic structure of the ectodomain from HIV-1 gp41 , 1997, Nature.

[67]  Deborah Fass,et al.  Core Structure of gp41 from the HIV Envelope Glycoprotein , 1997, Cell.

[68]  R. Siliciano,et al.  Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC. , 1995, Journal of immunology.

[69]  G Himmler,et al.  A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1 , 1993, Journal of virology.

[70]  J. Sodroski,et al.  Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding , 1993, Journal of virology.

[71]  Charles D Schwieters,et al.  The Xplor-NIH NMR molecular structure determination package. , 2003, Journal of magnetic resonance.